Disease Interception und Präzisionsmedizin. Zukunft der Medizin: Gesundheit anders denken und Krankheit anders behandeln
Table of contents
Bibliographic information

Open Access Full access
Disease Interception als Chance und Herausforderung
Eine interdisziplinäre Analyse
- Authors:
- | |
- Series
- Bochumer Schriften zum Sozial- und Gesundheitsrecht
- Volume
- 26
- Publisher
- Nomos, Baden-Baden
- Copyright year
- 2024
- ISBN-Print
- 978-3-7560-1633-4
- ISBN-Online
- 978-3-7489-4092-0
Chapter information
Open Access Full access
Disease Interception und Präzisionsmedizin. Zukunft der Medizin: Gesundheit anders denken und Krankheit anders behandeln
- Authors:
- ISBN-Print
- 978-3-7560-1633-4
- ISBN-Online
- 978-3-7489-4092-0
- Preview:
Bibliography
No match found. Try another term.
- Literaturverzeichnis Open Google Scholar doi.org/10.5771/9783748940920-19
- Barr, P. M. / Owen, C. / Robak, T. / Tedeschi, A. / Bairey, O. / Burger, J. A. / Hillmen, P. / Coutre, S. E. / Dearden, C. / Grosicki, S. / McCarthy, H. / Li, J.-Y. / Offner, F. / Zhou, C. / Hsu, E. / Szoke, A. / Kipps, T. J. / Ghia, P.: Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia, Blood Adv. 2022;6(11):3440–3450 (https://doi.org/10.1182/bloodadvances.2021006434). Open Google Scholar doi.org/10.5771/9783748940920-19
- Facon T. / Kumar, S. K. / Plesner, T. / Orlowski, R. Z. / Moreau, P. / Bahlis, N. / Basu, S. / Nahi, H. / Hulin, c. / Quach, H. / Goldschmidt, H. / O’Dwyer, Michael / Perrot, a. / Venner, C. P. / Weisel, K. / Mace, J. R. / Rage, N. / Tiab, M. / Macro, M. / Frenzel, L. / Leleu, X. / Ahmadi, T. / Wang, J. / van Rampelbergh, R. / Uhlar, C. M. / Tromp, B. / Delioukina, M. / Vermeulen, J. / Usmani, S. C.: Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial, Lancet Oncol. 2021; 22(11):1582–1596 (https://doi.org/10.1016/S1470-2045(21)00466-6). Open Google Scholar doi.org/10.5771/9783748940920-19
- Martin, T. / Usmani, S. Z. / Berdeja, J. G. / Agha, M. / Cohen, A. D. / Hari, P. / Avigan, S. / Deol, A. / Htut, M. / Lesokhin, al. / Munshi, N. C. / O’Donnel, E. / Stewart, a. K. / Schecter, J. M. / Goldberg, J. d. / Jackson, C. C. / Yeh, T.-M. / Banerjee, a. / Allred, A. / Zudaire, E. / Deraedt, W. / Olyslager, Y. / Zhou, C. / Pacaud, L. / Madduri, D. / Jakubowiak, A. / Lin, Y / Jagannath, S.: Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up, J Clin Oncol. 2023;41(6):1265–1274 (https://doi.org/10.1200/JCO.22.00842). Open Google Scholar doi.org/10.5771/9783748940920-19
- Rajkumar S. V. / Kumar, S. / Lonial, S. / Mateos, M. V.: Smoldering multiple myeloma current treatment algorithm, Blood Cancer Journal 2022;12:129 (https://doi.org/10.1038/s41408-022-00719-0). Open Google Scholar doi.org/10.5771/9783748940920-19